AWM
ABBV icon

Aevitas Wealth Management’s AbbVie ABBV Stock Holding History

Aevitas Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.52M Buy
15,608
+186
+1% +$28.5K 1.49% 18
2022
Q3 		$2.07M Buy
15,422
+23
+0.1% +$3.3K 1.56% 15
2022
Q2 		$2.36M Sell
15,399
-174
-1% -$26.6K 1.6% 15
2022
Q1 		$2.52M Sell
15,573
-784
-5% -$114K 1.54% 15
2021
Q4 		$2.21M Buy
16,357
+67
+0.4% +$7.91K 1.32% 18
2021
Q3 		$1.76M Sell
16,290
-131
-0.8% -$15K 1.12% 24
2021
Q2 		$1.85M Buy
16,421
+618
+4% +$69.6K 1.18% 22
2021
Q1 		$1.71M Buy
15,803
+198
+1% +$21.2K 1.19% 22
2020
Q4 		$1.67M Buy
15,605
+859
+6% +$82.5K 1.22% 24
2020
Q3 		$1.29M Buy
14,746
+7,498
+103% +$706K 1.06% 26
2020
Q2 		$761K Buy
7,248
+2,946
+68% +$259K 0.7% 39
2020
Q1 		$328K Buy
4,302
+12
+0.3% +$1.02K 0.37% 73
2019
Q4 		$380K Buy
4,290
+409
+11% +$34K 0.36% 72
2019
Q3 		$294K Sell
3,881
-289
-7% -$19.8K 0.29% 90
2019
Q2 		$303K Sell
4,170
-1,361
-25% -$107K 0.3% 87
2019
Q1 		$445K Buy
5,531
+3,048
+123% +$249K 0.4% 69
2018
Q4 		$229K Sell
2,483
-93
-4% -$8.18K 0.23% 92
2018
Q3 		$244K Sell
2,576
-393
-13% -$37.3K 0.22% 97
2018
Q2 		$275K Buy
2,969
+5
+0.2% +$488 0.27% 88
2018
Q1 		$280K Buy
2,964
+54
+2% +$5.93K 0.28% 85
2017
Q4 		$281K Buy
+2,910
New +$274K 0.27% 86

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aevitas Wealth Management's ABBV Position: Q4 2022 in Review

Aevitas Wealth Management increased its AbbVie (ABBV) stake by 1.2% in Q4 2022, buying an estimated $28.5K and bringing the position to 15,608 shares worth $2.52M. The position accounts for 1.49% of the portfolio, ranked #18.

Aevitas Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.52M in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Aevitas Wealth Management held 15,608 shares of AbbVie worth $2.52M as of Q4 2022.
  • Aevitas Wealth Management bought 186 AbbVie shares in Q4 2022, an estimated $28.5K.
  • AbbVie made up 1.49% of Aevitas Wealth Management's portfolio in Q4 2022, its #18 holding.
  • Aevitas Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 21 quarters since.
  • Aevitas Wealth Management's AbbVie position peaked at $2.52M in Q1 2022.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Aevitas Wealth Management's 13F filing for Q4 2022, filed 24 Jan 2023.